Abrn Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.00 M
- Revenue Growth 30.02%
- Profit Growth -19.22%
- Ebitda -16.65%
- Net Worth 69.81%
- Total Assets 250.44%
About Abrn Pharma
Abrn Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 July 2012 and has a history of 12 years and seven months. Its registered office is in Navi Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.00 M.
Rajendra Chauhan and Babita Chauhan serve as directors at the Company.
Company Details
-
Location
Navi Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24233MH2012PTC233151
-
Company No.
233151
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jul 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Abrn Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Chauhan
|
Director | 09-Jul-2012 | Current |
|
Babita Chauhan
|
Additional Director | 15-Jul-2016 | Current |
Financial Performance of Abrn Pharma.
Abrn Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.02% increase. The company also saw a substantial fall in profitability, with a 19.22% decrease in profit. The company's net worth Soared by an impressive increase of 69.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abrn Pharma?
In 2023, Abrn Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Oct 2020 | Axis Bank Limited | ₹7.00 M | Open |
How Many Employees Work at Abrn Pharma?
Unlock and access historical data on people associated with Abrn Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abrn Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abrn Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
